Correlation Between Eliem Therapeutics and Dominari Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Dominari Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Dominari Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Dominari Holdings, you can compare the effects of market volatilities on Eliem Therapeutics and Dominari Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Dominari Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Dominari Holdings.

Diversification Opportunities for Eliem Therapeutics and Dominari Holdings

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Eliem and Dominari is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Dominari Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dominari Holdings and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Dominari Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dominari Holdings has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Dominari Holdings go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Dominari Holdings

Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Dominari Holdings. In addition to that, Eliem Therapeutics is 1.68 times more volatile than Dominari Holdings. It trades about -0.38 of its total potential returns per unit of risk. Dominari Holdings is currently generating about -0.17 per unit of volatility. If you would invest  182.00  in Dominari Holdings on August 25, 2024 and sell it today you would lose (21.00) from holding Dominari Holdings or give up 11.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Eliem Therapeutics  vs.  Dominari Holdings

 Performance 
       Timeline  
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Dominari Holdings 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dominari Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating primary indicators, Dominari Holdings may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Eliem Therapeutics and Dominari Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eliem Therapeutics and Dominari Holdings

The main advantage of trading using opposite Eliem Therapeutics and Dominari Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Dominari Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dominari Holdings will offset losses from the drop in Dominari Holdings' long position.
The idea behind Eliem Therapeutics and Dominari Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm